dimethylethylsilylimidazole

vascular endothelial growth factor A ; Homo sapiens







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35411193 Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019. 2022 2
2 33253664 Retinal Fluid Volatility Associated With Interval Tolerance and Visual Outcomes in Diabetic Macular Edema in the VISTA Phase III Trial. 2021 Apr 1
3 32927780 A Pilot Study on MicroRNA Profile in Tear Fluid to Predict Response to Anti-VEGF Treatments for Diabetic Macular Edema. 2020 Sep 10 1
4 30222798 Letter to the Editor: Efficacy of the Intravitreal Sustained-Release Dexamethasone Implant for DME Refractory to Anti-VEGF Therapy: Meta-Analysis and Clinical Implications. 2018 Sep 1 1
5 28484955 Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges. 2017 Jun 4
6 25812378 [Pharmacological treatment for diabetic macular edema]. 2015 Mar 1
7 24339679 Systemic medical management of diabetic retinopathy. 2013 Oct-Dec 2
8 22132316 Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability. 2012 1
9 22523648 Combination therapy for diabetic macular edema. 2012 1
10 27195370 A Systematic Review of Intravitreal Bevacizumab for the Treatment of Diabetic Macular Edema 2011 1